Literature DB >> 33162316

Influence of Enema and Dietary Restrictions on Prostate MR Image Quality: A Multireader Study.

Andrei S Purysko1, Nathan Mielke2, Jennifer Bullen3, Douglas Nachand2, Alain Rizk2, Erica Stevens4, Ryan D Ward2, Eric A Klein5, Andrew B Rosenkrantz6, Justin M Ream2.   

Abstract

PURPOSE: To evaluate the effect of enema and dietary restrictions on prostate MR image quality metrics and to assess inter-reader agreement for these metrics.
METHODS: This retrospective study included 195 men divided into groups based on their compliance with preparation instructions before prostate MRI (Enema + Diet, n = 98; Enema, n = 42; Diet, n = 35; Control [no compliance], n = 20). Four readers independently assessed six image quality metrics on a 5-point scale. Between-group comparisons were made using Wilcoxon rank sum test. Inter-reader agreement was calculated using Fleiss' kappa.
RESULTS: Compared with the Control group, image quality with respect to rectal stool/gas, distortion of diffusion-weighted images, overall image quality, and confidence in assessment was higher in the Enema + Diet, Enema, and Diet groups (p  < 0.05 for all comparisons). The Enema + Diet and Enema groups had significantly higher scores than the Diet group for rectal stool/gas (p < 0.001 and 0.005, respectively). The Enema + Diet and Diet groups had higher scores than the Control group for rectal peristalsis (p = 0.027 and 0.009, respectively), but there were no significant differences in motion artifacts on T2-weighted images. Agreement among readers was fair, with kappa values ranging from 0.25 to 0.37.
CONCLUSION: Enema and dietary restriction can improve the quality of prostate MRI by decreasing rectal distension and distortion of diffusion-weighted images and by increasing reader confidence in image assessment. Inter-reader agreement using subjective criteria for analysis of MRI quality is fair.
Copyright © 2020 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diffusion Magnetic Resonance Imaging; Enema; Magnetic Resonance Imaging; Prostate

Mesh:

Year:  2020        PMID: 33162316     DOI: 10.1016/j.acra.2020.10.019

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

Review 1.  Deep learning-based artificial intelligence applications in prostate MRI: brief summary.

Authors:  Baris Turkbey; Masoom A Haider
Journal:  Br J Radiol       Date:  2021-12-03       Impact factor: 3.039

Review 2.  Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway.

Authors:  Tristan Barrett; Maarten de Rooij; Francesco Giganti; Clare Allen; Jelle O Barentsz; Anwar R Padhani
Journal:  Nat Rev Urol       Date:  2022-09-27       Impact factor: 16.430

3.  Value of bowel preparation techniques for prostate MRI: a preliminary study.

Authors:  Cynthia Schmidt; Andreas M Hötker; Urs J Muehlematter; Irene A Burger; Olivio F Donati; Borna K Barth
Journal:  Abdom Radiol (NY)       Date:  2021-03-26

4.  The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis.

Authors:  Devaki Shilpa S Surasi; Xuemei Wang; Tharakeswara K Bathala; Hyunsoo Hwang; Sandeep Arora; Antonio C Westphalen; Silvia D Chang; Baris Turkbey
Journal:  Abdom Radiol (NY)       Date:  2021-04-27

Review 5.  Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists.

Authors:  Francesco Giganti; Alex Kirkham; Veeru Kasivisvanathan; Marianthi-Vasiliki Papoutsaki; Shonit Punwani; Mark Emberton; Caroline M Moore; Clare Allen
Journal:  Insights Imaging       Date:  2021-05-01

Review 6.  Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score.

Authors:  Francesco Giganti; Veeru Kasivisvanathan; Alex Kirkham; Shonit Punwani; Mark Emberton; Caroline M Moore; Clare Allen
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.039

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.